STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7
Clinical trials for STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a second drug boost cancer treatment power?
Disease control CompletedThis study tested whether adding the drug bevacizumab to standard immunotherapy (ipilimumab) could help patients with advanced melanoma live longer. It involved 169 adults whose cancer could not be removed by surgery. Participants were randomly assigned to receive either the sing…
Matched conditions: STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Skin cream plus IV drug: a new attack on deadly melanoma?
Disease control CompletedThis small, early study tested if combining two immune-boosting treatments could help control advanced melanoma. Seven patients with stage IIIB-IV skin cancer that couldn't be surgically removed received pembrolizumab (an IV drug) and applied imiquimod (a cream) to skin lesions. …
Matched conditions: STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC